May 29, 2019 - Key highlights of the past week include regulatory approvals, collaborations and pipeline updates.
May 27, 2019 - Incyte (INCY) obtains FDA approval for a third indication of lead drug, Jakafi, for the treatment of GVHD.
May 24, 2019 - Top Stock Reports for Medtronic, TJX Companies & Deere
May 01, 2019 - Key highlights of the past week are earnings releases by most leading biotech entities.
Apr 30, 2019 - INCY earnings call for the period ending March 31, 2019.
Apr 30, 2019 - Incyte Corporation (NASDAQ:INCY) Q1 2019 Earnings Conference Call April 30, 2019 08:00 AM ET Company Participants Mike Booth - IR Hervé Hoppenot - CEO Barry Flannelly - EVP, General Manager, U.S. Stev
Apr 30, 2019 - While Incyte's (INCY) earnings and revenues beat estimates in Q1, Jakafi sales fall short of the same.
Apr 29, 2019 - Incyte (INCY) is slated to report first-quarter results on Apr 30. Investors will primarily focus on Jakafi sales and pipeline updates.
Apr 29, 2019 - Sarepta Therapeutics' (SRPT) Exondys 51 likely to drive first-quarter sales.
Apr 26, 2019 - Strong sales of Glaxo's (GSK) Vaccines segment is likely to drive the top line in the first quarter.